What’s New in Surgery for Kidney Cancer?
Patient number RECIST PFS (months) Survival (months) SLTS (%) Primary (%) Metastates (%) Overall (%) Overall 1 -9 -9 4 -1 SD 10 18+ 2 – – – – –…
Patient number RECIST PFS (months) Survival (months) SLTS (%) Primary (%) Metastates (%) Overall (%) Overall 1 -9 -9 4 -1 SD 10 18+ 2 – – – – –…
Phase II trials N. Design RT dose CR Median F/U 3 yr DFS 3 yr CFS OS RTOG-0529 phase II completed accrual March 2008 63 5FU 1000 mg/m2 days 1–4…
Andrea Valeri, Carlo Bergamini, Ferdinando Agresta and Jacopo Martellucci (eds.)What’s New in Surgical OncologyA Guide for Surgeons in Training and Medical/Radiation Oncologists10.1007/978-88-470-5310-6_2 © Springer-Verlag Italia 2013 2. Gastric Malignancies Domenico Garcea2, Andrea Rinnovati1 and Paolo Morgagni2 (1) General Surgery Unit,…
17. Valle M, Federici O, Garofalo A (2012) Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surg Oncol Clin N…
n. Compl Pulm Anast M Morita [36] Surgery alone 253 24,5% 9,9% 13% 2,4% Preoperative CRT 197 40,1% 14,7% 23,4% 2,0% Salvage surgery 27 59,3% 29,6% 37% 7,4% Miyata…
11. Bonvalot S, Eldweny H, Pechoux CL et al (2006) Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Ann Surg Oncol 13: 1596–1603PubMedCrossRef 12. DeMatteo…
Papillary and follicular thyroid carcinoma Tx Primary tumor cannot be assessed T0 No evidence of primary tumor T1 Tumor size ≤2 cm and limited to the thyroid gland T1a: Tumor…